{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:34:30Z","timestamp":1787510070877,"version":"build-2736575974"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute pancreatitis (AP) incidence is ~76.2 per 100,000. Drug-induced pancreatitis (DIP) accounts for &amp;lt;2%, yet &amp;gt;500 drugs are implicated. Evidence linking the SSRI paroxetine to AP remains sparse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 28-year-old woman with severe depression self-initiated paroxetine 20\u202fmg once daily; within 24\u202fh she developed persistent epigastric pain and bloating. After brief relief with intravenous fluids she re-administered the same dose, and symptoms recurred within 24\u202fh. Labs showed elevated pancreatic enzymes and CRP. CT revealed mild pancreatitis. No alcohol, hyperlipidemia or other classic risk factors were identified. Paroxetine was immediately discontinued; supportive care led to symptom and enzyme normalization within 72\u202fh. She was discharged on trazodone and remains recurrence-free.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      Population studies have not established a significant SSRI\u2013AP association, probably because of the extreme rarity of such events (&amp;lt;0.01%). The positive rechallenge observed here provides robust individual-level evidence of causality, supported by formal probability scales and international criteria. SSRIs may precipitate AP through serotonin-mediated\n                      <jats:italic>\u03b2<\/jats:italic>\n                      -cell dysfunction, oxidative stress, or idiosyncratic hypersensitivity. Early recognition is critical because DIP is usually reversible after drug withdrawal.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case suggests that paroxetine may induce AP even at standard doses. Clinicians should consider DIP in patients lacking traditional risk factors, especially after self-rechallenge. Early recognition, immediate drug cessation and supportive therapy ensure excellent recovery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1688065","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T06:36:22Z","timestamp":1767594982000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: A case of drug-induced pancreatitis caused by paroxetine with a literature review"],"prefix":"10.3389","volume":"12","author":[{"given":"Yangpeng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DongFeng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YaDong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S0140-6736(20)31310-6","article-title":"Acute pancreatitis","volume":"396","author":"Boxhoorn","year":"2020","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1046\/j.1365-2036.2003.01485.x","article-title":"Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis","volume":"17","author":"Lancashire","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/01.yic.0000066455.73432.d2","article-title":"Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: data from the world health organization (who) database of adverse drug reactions","volume":"18","author":"Spigset","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/cpt.3139","article-title":"Drug-induced acute pancreatitis: a real-world pharmacovigilance study using the fda adverse event reporting system database","volume":"115","author":"Li","year":"2024","journal-title":"Clin Pharmacol Ther"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5414\/cpp45289","article-title":"Fatal hyponatremia and other metabolic disturbances associated with psychotropic drug polypharmacy","volume":"45","author":"Vucicevic","year":"2007","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/JCP.0b013e318058a9c3","article-title":"Selective serotonin reuptake inhibitors and risk of acute pancreatitis: a population-based case-control study","volume":"27","author":"Norgaard","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e231883","DOI":"10.1371\/journal.pone.0231883","article-title":"Drug induced pancreatitis: a systematic review of case reports to determine potential drug associations","volume":"15","author":"Wolfe","year":"2020","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3892\/br.2024.1816","article-title":"Effects of selective serotonin reuptake inhibitors on endocrine system (review)","volume":"21","author":"Ruiz-Santiago","year":"2024","journal-title":"Biomed Rep"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"710616112","DOI":"10.1177\/1559325820902352","article-title":"The risk of acute pancreatitis and selective serotonin reuptake inhibitors use: a meta-analysis of case-control studies","volume":"18","author":"Lai","year":"2020","journal-title":"Dose Resp"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/ije\/dyac071","article-title":"Investigation of the potential association between the use of fluoxetine and occurrence of acute pancreatitis: a danish register-based cohort study","volume":"51","author":"Aakjaer","year":"2022","journal-title":"Int J Epidemiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1042\/BSR20180967","article-title":"The effect of selective serotonin re-uptake inhibitors on risk of type ii diabetes mellitus and acute pancreatitis: a meta-analysis","volume":"38","author":"Yao","year":"2018","journal-title":"Biosci Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jad.2014.04.063","article-title":"Fluoxetine-induced pancreatic beta cell dysfunction: new insight into the benefits of folic acid in the treatment of depression","volume":"166","author":"De Long","year":"2014","journal-title":"J Affect Disord"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1074\/jbc.AAC118.002476","article-title":"Selective serotonin reuptake inhibitors (ssris) inhibit insulin secretion and action in pancreatic beta cells","volume":"293","author":"Isaac","year":"2018","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1517\/14656566.9.5.787","article-title":"Paroxetine","volume":"9","author":"Tang","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/gut.37.4.565","article-title":"Drug induced acute pancreatitis: incidence and severity","volume":"37","author":"Lankisch","year":"1995","journal-title":"Gut"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s002280100346","article-title":"Spontaneous reports on drug-induced pancreatitis in Denmark from 1968 to 1999","volume":"57","author":"Andersen","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e621","DOI":"10.14309\/ctg.0000000000000621","article-title":"Drug-induced acute pancreatitis: an evidence-based classification (revised)","volume":"14","author":"Saini","year":"2023","journal-title":"Clin Transl Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"953","DOI":"10.47391\/JPMA.9280","article-title":"Acute pancreatitis: a narrative review","volume":"74","author":"Sohail","year":"2024","journal-title":"J Pak Med Assoc"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ajg.2019.11.005","article-title":"Drug-induced pancreatitis: an update","volume":"20","author":"Zheng","year":"2019","journal-title":"Arab J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.pan.2020.07.401","article-title":"Drug-induced acute pancreatitis: prevalence, causative agents, and outcomes","volume":"20","author":"Chadalavada","year":"2020","journal-title":"Pancreatology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2165\/00002018-200831100-00002","article-title":"Drug-induced pancreatitis: incidence, management and prevention","volume":"31","author":"Balani","year":"2008","journal-title":"Drug Saf"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"645","DOI":"10.2165\/00002018-200528070-00006","article-title":"From the Uppsala monitoring Centre: a review of viewpoint part 1 and part 2","volume":"28","author":"Hugman","year":"2005","journal-title":"Drug Saf"},{"key":"ref24","volume-title":"Paroxetine-induced acute pancreatitis: case report. Turk J Gastroenterol.","author":"Pamukcu","year":"2009"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.11604\/pamj.2015.20.112.6024","article-title":"Acute myelomonocytic leukemia eosinophilic revealed by acute pancreatitis","volume":"20","author":"Touaoussa","year":"2015","journal-title":"Pan Afr Med J"},{"key":"ref26","first-page":"177","article-title":"Selective serotonin uptake inhibitors and pancreatitis","volume":"121","author":"Kvande","year":"2001","journal-title":"Tidsskrift for Den Norske Legeforening"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1590\/s1516-44462004000100011","article-title":"Sertraline and acute pancreatitis: a case-report","volume":"26","author":"Malbergier","year":"2004","journal-title":"Braz J Psychiatry"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.7869\/tg.199","article-title":"Acute necrotizing pancreatitis following olanzapine therapy","volume":"35","author":"Gupta","year":"2014","journal-title":"Trop Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"bcr2015209571","DOI":"10.1136\/bcr-2015-209571","article-title":"Quetiapine-induced hypertriglyceridaemia causing acute pancreatitis","volume":"2015","author":"Franco","year":"2015","journal-title":"BMJ Case Rep"},{"key":"ref30","first-page":"318","article-title":"Sertraline-induced acute pancreatitis: a case report and literature review","volume":"10","author":"Yang","year":"2024","journal-title":"Altern Ther Health Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1053\/j.gastro.2020.07.016","article-title":"Analysis of 1060 cases of drug-induced acute pancreatitis","volume":"159","author":"Meczker","year":"2020","journal-title":"Gastroenterology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.51821\/88.1.13722","article-title":"Gliptin induced acute pancreatitis: a literature review","volume":"88","author":"Jaya","year":"2025","journal-title":"Acta Gastroenterol Belg"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1688065\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T06:36:27Z","timestamp":1767594987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1688065\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":32,"alternative-id":["10.3389\/fmed.2025.1688065"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1688065","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"article-number":"1688065"}}